Morgan Stanley

13F Holdings History for Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 3.43M shares
Security Ownership: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

2025-02-03 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.43M shares of Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK). This represents 6.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	6.5%		$24.1M	3.43M			$7.02	13G/A	12/31/2024	3 Feb 2025 16:36:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	0%	$83.1M	3.54M	-36,926	-1.03%	$23.50	Q3 2025
6/30/2025	0%	0%	$40.6M	3.57M	-16,849	-0.47%	$11.35	Q2 2025
3/31/2025	0%	+0%	$23.9M	3.59M	+153,581		$6.65	Q1 2025
12/31/2024	0%	0%	$37.9M	3.44M	-768,063		$11.03	Q4 2024
9/30/2024	0%	+0%	$51.7M	4.21M	+726,510		$12.29	Q3 2024
6/30/2024	0%	0%	$47M	3.48M	-546,205		$13.51	Q2 2024
3/31/2024	0%		$54.3M	4.03M			$13.50	Q1 2024
12/31/2023	0%		$17.7M	3.37M			$5.26	Q4 2023
9/30/2023	0%	0%	$11.5M	2.91M	-7,292	-0.25%	$3.94	Q3 2023
6/30/2023	0%	0%	$31.1M	2.92M	-3,452	-0.12%	$10.63	Q2 2023
3/31/2023	0%	+0%	$24.4M	2.92M	+470,842	+19.2%	$8.33	Q1 2023
12/31/2022	0%	0%	$22.6M	2.45M	-158,349	-6.06%	$9.23	Q4 2022
9/30/2022	0%	0%	$33.5M	2.61M	-3,839	-0.15%	$12.84^*	Q3 2022
6/30/2022	0%	+0%	$34.6M	2.62M	+63,745	+2.5%	$13.21^*	Q2 2022
3/31/2022	0.01%	+0.01%	$53.7M	2.55M	+2,428,527	+1965%	$21.05^*	Q1 2022
12/31/2021	0%	0%	$2.97M	124K	-18,123	-12.8%	$24.00	Q4 2021
9/30/2021	0%		$3.61M	142K			$25.44	Q3 2021
6/30/2021	0%	0%	$6.55M	194K	-22,445	-10.3%	$33.67	Q2 2021
3/31/2021	0%	+0%	$8.43M	217K	+205,971	+1879%	$38.84	Q1 2021
12/31/2020	0%	+0%	$679K	11K	+7,899	+258%	$61.93	Q4 2020
9/30/2020	0%	0%	$102K	3.07K	-47,525	-93.9%	$33.28	Q3 2020
6/30/2020	0%	+0%	$1.21M	50.6K	+45,489	+892%	$23.84	Q2 2020
3/31/2020	0%	0%	$117K	5.1K	-12,398	-70.8%	$22.94	Q1 2020
12/31/2019	0%	+0%	$496K	17.5K	+11,459	+190%	$28.34	Q4 2019
9/30/2019	0%	+0%	$130K	6.04K	+2,490	+70.1%	$21.52	Q3 2019
6/30/2019	0%	+0%	$104K	3.55K	+3,550	NEW	$29.30	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.